Promising Mid Cap Stocks To Follow Now – November 9th

IREN, Hims & Hers Health, Trade Desk, American Airlines Group, Applied Optoelectronics, TeraWulf, and Ionis Pharmaceuticals are the seven Mid Cap stocks to watch today, according to MarketBeat’s stock screener tool. Mid-cap stocks are shares of companies with a medium-sized market capitalization, generally between small-cap and large-cap companies; the exact size range varies by index or definition. Investors may view them as offering more growth potential than many large-cap stocks, but they can also be more volatile and carry greater risk. These companies had the highest dollar trading volume of any Mid Cap stocks within the last several days.

IREN (IREN)

IREN Limited, formerly known as Iris Energy Limited, owns and operates bitcoin mining data centers. The company was incorporated in 2018 and is headquartered in Sydney, Australia.

IREN traded up $0.21 during midday trading on Monday, hitting $21.85. 64,073,404 shares of the company’s stock traded hands, compared to its average volume of 44,668,637. The company has a debt-to-equity ratio of 1.77, a current ratio of 1.60 and a quick ratio of 1.60. The company has a market cap of $8.61 billion, a PE ratio of -5.31 and a beta of 4.33. The stock’s fifty day simple moving average is $35.87 and its 200-day simple moving average is $43.60. IREN has a one year low of $17.16 and a one year high of $70.71.

Hims & Hers Health (HIMS)

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

HIMS stock traded down $2.55 during trading hours on Monday, hitting $23.45. The company’s stock had a trading volume of 28,590,610 shares, compared to its average volume of 22,130,754. The stock has a 50 day moving average price of $28.43 and a two-hundred day moving average price of $26.94. Hims & Hers Health has a 12 month low of $13.74 and a 12 month high of $42.70. The company has a market capitalization of $5.47 billion, a PE ratio of -37.20 and a beta of 2.53. The company has a quick ratio of 0.87, a current ratio of 0.93 and a debt-to-equity ratio of 4.21.

Trade Desk (TTD)

The Trade Desk, Inc. operates as a technology company in the United States and internationally. The company offers a self-service cloud-based platform that allows buyers to plan, manage, optimize, and measure data-driven digital advertising campaigns across various ad formats and channels, including video, display, audio, digital-out-of-home, native, and social on various devices, such as computers, mobile devices, televisions, and streaming devices.

Shares of Trade Desk stock traded up $2.25 during midday trading on Monday, reaching $15.18. 43,459,690 shares of the company’s stock traded hands, compared to its average volume of 19,976,840. The company has a market cap of $7.13 billion, a price-to-earnings ratio of 18.07, a price-to-earnings-growth ratio of 1.40 and a beta of 0.98. The company’s 50 day simple moving average is $13.06 and its 200 day simple moving average is $19.62. Trade Desk has a 52 week low of $11.62 and a 52 week high of $45.50.

American Airlines Group (AAL)

American Airlines Group Inc., through its subsidiaries, operates as a network air carrier. The company provides scheduled air transportation services for passengers and cargo through its hubs in Charlotte, Chicago, Dallas/Fort Worth, Los Angeles, Miami, New York, Philadelphia, Phoenix, and Washington, D.C., as well as through partner gateways in London, Doha, Madrid, Seattle/Tacoma, Sydney, and Tokyo.

NASDAQ:AAL traded up $1.14 during trading hours on Monday, reaching $14.32. The company’s stock had a trading volume of 45,584,463 shares, compared to its average volume of 76,678,914. The company has a market cap of $9.49 billion, a price-to-earnings ratio of -19.54 and a beta of 1.45. American Airlines Group has a one year low of $10.09 and a one year high of $18.79. The business’s 50-day moving average is $12.88 and its 200-day moving average is $13.51.

Applied Optoelectronics (AAOI)

Applied Optoelectronics, Inc. designs, manufactures, and sells fiber-optic networking products in the United States, Taiwan, and China. It offers optical modules, optical filters, lasers, laser components, subassemblies, transmitters and transceivers, turn-key equipment, headend, node, distribution equipment, and amplifiers.

Applied Optoelectronics stock traded up $2.20 during mid-day trading on Monday, hitting $52.33. 10,633,404 shares of the company’s stock were exchanged, compared to its average volume of 10,629,358. Applied Optoelectronics has a 1-year low of $18.50 and a 1-year high of $233.67. The stock has a 50 day moving average of $92.96 and a two-hundred day moving average of $113.25. The company has a current ratio of 2.34, a quick ratio of 1.77 and a debt-to-equity ratio of 0.10. The stock has a market cap of $4.43 billion, a P/E ratio of -121.20 and a beta of 4.04.

TeraWulf (WULF)

Shares of NASDAQ:WULF traded up $1.01 on Monday, reaching $12.38. The company had a trading volume of 42,471,973 shares, compared to its average volume of 33,384,844. TeraWulf has a twelve month low of $9.51 and a twelve month high of $29.84. The stock has a 50-day moving average price of $14.21 and a 200 day moving average price of $17.95. The stock has a market capitalization of $6.18 billion, a P/E ratio of -3.74 and a beta of 4.00. The company has a quick ratio of 0.75, a current ratio of 0.75 and a debt-to-equity ratio of 27.25.

Ionis Pharmaceuticals (IONS)

Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an antisense injection for the treatment of polyneuropathy caused by hereditary transthyretin amyloidosis in adults; and WAYLIVRA, an antisense medicine for treatment for familial chylomicronemia syndrome (FCS) and familial partial lipodystrophy.

Shares of IONS traded down $9.03 during trading hours on Monday, hitting $30.39. 13,956,733 shares of the company were exchanged, compared to its average volume of 2,718,941. The company has a debt-to-equity ratio of 3.07, a quick ratio of 7.73 and a current ratio of 7.89. The company has a market cap of $5.05 billion, a PE ratio of -8.79 and a beta of 0.43. The firm’s 50 day moving average is $46.80 and its 200-day moving average is $65.88. Ionis Pharmaceuticals has a 52 week low of $27.75 and a 52 week high of $86.74.